{
    "SPADE_UN_18943": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_18943",
            "Peptide Name": "Retrocd4 (cyclic dimeric KR-12, synthetic AMPs, UCBB1; Derivative: retro-ld*)",
            "Source": "designed, human cathelicidin analog, animal-derived, natural derivative",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "AGGKRIVQRIKDFLRGAGGRLFDKIRQVIRKG",
            "Sequence Length": 32,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Antifungal",
                "Antifungal"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 3610.27,
            "PI": 12.0,
            "Hydrophobicity": -0.49,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Gunasekera S, Muhammad T, Strömstedt AA, Rosengren KJ, Göransson U.2020",
                    "Reference": "Front Microbiol. 2020 Feb 21;11:168. doi: 10.3389/fmicb.2020.00168.PubMed",
                    "Title": "Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability."
                }
            ],
            "Frequent Amino Acids": "GRI",
            "Absent Amino Acids": "CEHMNOPSTUWY",
            "Basic Residues": 10,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 12,
            "Polar Residues": 16,
            "Positive Residues": 10,
            "Negative Residues": 2,
            "Net Charge": 8,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (67.57%) tocd4K: 13%, R: 19%, I: 13%, G: 19%.Activity:  active against E. coli (MIC 1.25 uM), P. aeruginosa (MIC 0.625 uM), S. aureus (MIC 1.25  uM), and C. albicans (MIC 2.5  uM). Warning: Non-standard assay.SAR: the linear form of this peptide has activity similar to the cyclic form.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_00404",
                    "Similarity": 1.0,
                    "Sequence": "KRIVQRIKDFLR"
                },
                {
                    "SPADE_ID": "SPADE_UN_25884",
                    "Similarity": 1.0,
                    "Sequence": "KRIVQRIK"
                },
                {
                    "SPADE_ID": "SPADE_UN_25885",
                    "Similarity": 1.0,
                    "Sequence": "KRIVQRIK"
                }
            ]
        }
    }
}